| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.25 | 4e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.22 | 0.0004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |